Skip to main content

FEMASYS INC

For the period ended Dec 31, 2024. Filed Mar 27, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 27, 2025

FEMY$1.43+0.7%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 15. Exhibits, Financial Statement Schedules

Item 15.Exhibits.
Exhibit NumberDescription of DocumentSchedule/FormExhibitFiling Date
3.1Eleventh Amended and Restated Certificate of Incorporation of Femasys Inc.Form 8-K3.1June 22, 2021
3.2Amended and Restated Bylaws of Femasys Inc.Form 8-K3.2June 22, 2021
3.3First Amendment to the Amended and Restated Bylaws of Femasys Inc., dated as of March 29, 2023Form 8-K3.1March 30, 2023
4.2Form of Certificate of Common StockForm S-14.1May 14, 2021
4.3Form of indentureForm S-34.3July 1, 2022
4.4Form of Pre-Funded WarrantForm 8-K4.1April 20, 2023
4.5Form of Common Stock WarrantForm 8-K4.2April 20, 2023
4.6Form of Placement Agent WarrantForm 8-K4.3April 20, 2023
4.7Form of Series A WarrantForm 8-K4.1November 15, 2023
4.8Form of Series B WarrantForm 8-K4.2November 15, 2023
10.1Femasys Inc. 2021 Equity Incentive Plan, and forms of agreements thereunderForm S-110.3May 14, 2021
10.2Femasys Inc. 2021 Employee Stock Purchase PlanForm S-110.4May 14, 2021
10.3Amended and Restated Employment Agreement, by and between Femasys Inc. and Kathy Lee-SepsickForm S-1/A10.6June 14, 2021
10.4Amended and Restated Employment Agreement, by and between Femasys Inc. and Daniel CurrieForm S-1/A10.8June 14, 2021
10.5Femasys Inc. Non-Employee Director Compensation PolicyForm S-1/A10.11June 14, 2021
10.6Form of Indemnification Agreement between Femasys Inc. and its directors and officersForm S-110.12May 14, 2021
10.7Master Services Agreement and Statement of Work for consulting services, effective August 12, 2021, by and between Femasys Inc. and Bespoke Medical Affairs Solutions, LLCForm 10-Q10.1November 12, 2021
10.8Employment Agreement, dated as of February 28, 2022, between Femasys Inc. and Dov ElefantForm 8-K10.1February 24, 2022
10.9Form of Inducement Stock Option AgreementForm 8-K10.2February 24, 2022
10.10Equity Purchase Agreement dated July 1, 2022, between Femasys Inc. and Piper Sandler & Co.Form S-31.2July 1, 2022
10.11Form of Purchase AgreementForm 8-K10.1November 15, 2023
10.12Form of Convertible NoteForm 8-K10.2November 15, 2023
10.13Form of Registration Rights AgreementForm 8-K10.3November 15, 2023
10.14Form of Collaboration AgreementForm 8-K10.4November 15, 2023
19.1*Insider Trading Policy
23.1*Consent of KPMG LLP
24.1*Power of Attorney (included on signature page)
31.1*Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1*Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2*Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
97.1Clawback Policy
101.INS*Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
101.SCH*Inline XBRL Taxonomy Extension Schema Document
101.CAL*Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE*Inline XBRL Taxonomy Extension Presentation Linkbase Document
104*Cover Page Interactive Data File (formatted as inline XRBL and contained in Exhibit 101)
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.